Our Businesses – MDS Nordion

Overview
A global leader in providing medical isotopes for molecular and diagnostic imaging, radiotherapeutics and sterilization technologies. Customers count on MDS Nordion to supply isotopes for cardiac imaging, targeted cancer treatments and sterilization of medical products. In addition, customers look to MDS Nordion for unique collaborations to bring novel molecular imaging agents and radiotherapeutics to market.

Market Segments Medical isotopes Radiotherapeutics Sterilization technologies

Key 2008 Achievements and Improvements

• Streamlined business portfolio with the divestiture of external-beam therapy and self-contained irradiators product lines.
• Grew business for TheraSphere^®, an innovative treatment for liver cancer, by almost 50%.
• Supported world demand for medical isotopes during the shutdown of a nuclear reactor in European Union.
• Achieved record sales for Cobalt-60.
• Celebrated a 30-year partnership with TRIUMF, a world-class physics research laboratory located on the campus of the University of British Columbia.

			Key 2009 Priorities Expand existing product offerings into new global markets. Increase internal pipeline of products under development and leverage research-and-development partnerships. Continue application of LeanSigma tools to drive operational efficiencies and to improve customer service.